|
Mar 12
|
ACHV: 2Q:25 NDA Submission
|
|
Mar 12
|
Q4 2024 Achieve Life Sciences Inc Earnings Call
|
|
Mar 12
|
Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
|
Mar 11
|
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program
|
|
Feb 18
|
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)
|